ExploR&D Clinical Program Lead at Eli Lilly and Company

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Ability to lead multiple collaboration teams comprised of ExploR&D personnel, LRL subject matter experts, and external biotech collaborators
Expertise in creating high-performing teams with a culture of trust, autonomy, agency, collaboration, and inclusion
Proficiency in contemporary project management tools and approaches to deliver projects on time, on budget, and within scope from discovery/pre-clinical development through clinical proof-of-concept
Capability to identify and synthesize relevant technical information from scientific literature, internal/external experts, and experimental/trial data to guide study design and program strategy
Skills in providing and critically evaluating content for critical documents (e.g., Investigator Brochures, Risk Profiles, Study Protocols, Study Reports, Regulatory and Ethical filings)
Experience serving as a scientific leader for rationale, integration of cross-functional data, risk/benefit profile synthesis, strategic conclusions, and data-driven decision making
Strong collaboration and relationship management skills as primary liaison with external biotech collaborators, fostering relationships, transparent communication, and alignment on goals
Ability to anticipate and resolve barriers, identify roadblocks early, offer innovative solutions, and execute programs with excellence
Capacity to create a 'partner of choice' experience, accounting for partner goals/priorities and optimizing strategic plans with an entrepreneurial drug developer mindset

Responsibilities

Lead multiple collaboration teams comprised of ExploR&D personnel, LRL subject matter experts, and external biotech collaborators
Create a high-performing team with a culture of trust, autonomy, agency, collaboration, and inclusion
Deliver projects ‘on time, on budget’, and within scope from discovery/pre-clinical development through clinical proof-of-concept using contemporary project management tools and approaches
Identify and synthesize relevant technical information from various sources to address key questions and guide study design and program strategy
Provide and critically evaluate content within critical documents (e.g., Investigator Brochures, Risk Profiles, Study Protocols, Study Reports, Regulatory and Ethical filings and updates)
Serve as the ExploR&D scientific leader responsible for rationale, integration of cross-functional data, synthesis of the risk/benefit profile, strategic conclusions, and designs to drive data-driven decision making
Serve as primary liaison between Lilly and external biotech collaborators, fostering strong relationships, transparent communication, and ensuring alignment on project goals
Anticipate and resolve barriers to success by identifying potential roadblocks early, offering innovative solutions, and ensuring collaboration programs are executed with excellence
Create a ‘partner of choice’ experience accounting for partner’s goals and priorities, optimizing strategic plans with the spirit of an entrepreneurial drug developer

Skills

Key technologies and capabilities for this role

drug discoveryclinical developmentproject managementcross-functional leadershipstrategic planningbudget managementtimeline managementR&Dbiotech collaborationprogram execution

Questions & Answers

Common questions about this position

What is the employment type for this position?

This is a full-time position.

Is this role remote or does it require working from a specific location?

This information is not specified in the job description.

What are the key skills required for the ExploR&D Clinical Program Lead role?

The role requires skills in team leadership, project management, and scientific/technical leadership, including leading cross-functional teams, delivering projects on time and budget, and synthesizing technical information to guide strategy.

What is the company culture like at Lilly ExploR&D?

The culture emphasizes creating high-performing teams with trust, autonomy, agency, collaboration, and inclusion, while putting people first and uniting caring with discovery.

What makes a strong candidate for this Program Lead position?

Strong candidates will have experience leading cross-functional teams in drug discovery and development, expertise in project management to deliver on time and budget, and the ability to provide scientific leadership by synthesizing technical information.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free